Generation of inhibitory DNA aptamers against human hepatocyte growth factor

被引:14
作者
Saito, T
Tomida, M
机构
[1] Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan
[2] Saitama Small Enterprise Promot Corp, REDS Grp, JST, Saitama Prefecture Collaborat Reg Entities Advanc, Kawaguchi, Japan
关键词
D O I
10.1089/dna.2005.24.624
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor (HGF), a multifunctional cytokine, can act on many cell types. It is involved in cancer growth and metastasis by enhancing the motility of cancer cells and stimulating angiogenesis. The development of effective inhibitors for HGF is an important issue in cancer therapy. In this study, we isolated DNA aptamers against human HGF using the systematic evolution of ligands by exponential enrichment method. The selected DNA aptamers had a highly conserved consensus sequence, and could be divided into two major classes ( classes I and II). The consensus motif of classes I and II might contribute to the formation of a hairpin loop structure and a G-quartet structure, respectively. These DNA aptamers bound to human HGF with high affinity and specificity. The dissociation constants of typical aptamers H38-15 and H38-21, representative of the two classes, were calculated to be approximately 20 nM. H38-15 and H38-21 inhibited the biological activities of HGF including the stimulation of scattering, migration, and invasion of pancreatic cancer KP-3 cells. Furthermore, both aptamers inhibited HGF-induced tube formation by human umbilical vein endothelial cells. These results suggested that the isolated DNA aptamers will be useful as therapeutic and diagnostic reagents for cancers.
引用
收藏
页码:624 / 633
页数:10
相关论文
共 61 条
[1]   DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity [J].
Andreola, ML ;
Pileur, F ;
Calmels, C ;
Ventura, M ;
Tarrago-Litvak, L ;
Toulmé, JJ ;
Litvak, S .
BIOCHEMISTRY, 2001, 40 (34) :10087-10094
[2]  
Bharti A, 2004, ANTICANCER RES, V24, P1031
[3]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[4]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[5]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[6]   Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models [J].
Cao, B ;
Su, YL ;
Oskarsson, M ;
Zhao, P ;
Kort, EJ ;
Fisher, RJ ;
Wang, LM ;
Vande Woude, GF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7443-7448
[7]   Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction [J].
Date, I ;
Takagi, N ;
Takagi, K ;
Kago, T ;
Matsumoto, K ;
Nakamura, T ;
Takeo, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (04) :1152-1158
[8]   HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor [J].
Date, K ;
Matsumoto, K ;
Shimura, H ;
Tanaka, M ;
Nakamura, T .
FEBS LETTERS, 1997, 420 (01) :1-6
[9]   The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo [J].
Davies, G ;
Mason, MD ;
Martin, TA ;
Parr, C ;
Watkins, G ;
Lane, J ;
Matsumoto, K ;
Nakamura, T ;
Jiang, WG .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :348-354
[10]  
DIRENZO MF, 1991, ONCOGENE, V6, P1997